The Kaposi's sarcoma associated herpes virus (KSHV/HHV-8) is a gammaherpesvirus associated with human malignancies including Kaposi's sarcoma and body cavity based lymphomas (BCBLs) or Pleural Effusion Lymphomas (PELs). One of the latency-associated nuclear antigen (LANA) is constitutively expressed in all latently infected KSHV cells and is incloved in the maintenance of the KSHV genome as well as transcriptional regulation. Recent studies has also shown an important role in regulation of vial latency in association with the viral immediate early transactivator Rta. Studies from our group and others have shown that LANA binds to cis-acting elements withing the KSHV terminal repeats (TR) and associated with a number of chromosomal proteins. Additionally, LANA can induce chromosomal aberations when expressed in human cells in vitro suggesting a role for LANA in induction of oncogenesis in KSHV infected cells.
The specific aims of this proposal will continue to focus on studies of KSHV latent replication in a LANA dependent and independent mode.
Specific aims will focus on 1) The identification and characterization of specific sites within the KSHV genome capable of initiating KSHV latent replication;2) Determine the role of LANA and other cellular proteins in terms of the dynamics of protein-DNA interactions at these sites of latent replication for firing of these replication initiation sites;and 3) Genetic analysis of LANA and these replication initiation sites for determination of the role of the cis and trans acting factors during the initial stages of infection and maintenance of KSHV latent replication.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-AARR-C (04))
Program Officer
Ogunbiyi, Peter
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pennsylvania
Schools of Medicine
United States
Zip Code
Dzeng, Richard K; Jha, Hem Chandra; Lu, Jie et al. (2015) Small molecule growth inhibitors of human oncogenic gammaherpesvirus infected B-cells. Mol Oncol 9:365-76
Verma, Subhash C; Cai, Qiliang; Kreider, Edward et al. (2013) Comprehensive analysis of LANA interacting proteins essential for viral genome tethering and persistence. PLoS One 8:e74662
Jha, Hem Chandra; Upadhyay, Santosh Kumar; A J Prasad, Mahadesh et al. (2013) H2AX phosphorylation is important for LANA-mediated Kaposi's sarcoma-associated herpesvirus episome persistence. J Virol 87:5255-69
Cai, Qiliang; Xiao, Bingyi; Si, Huaxin et al. (2012) Kaposi's sarcoma herpesvirus upregulates Aurora A expression to promote p53 phosphorylation and ubiquitylation. PLoS Pathog 8:e1002566
Lu, Jie; Verma, Subhash C; Cai, Qiliang et al. (2012) The RBP-J? binding sites within the RTA promoter regulate KSHV latent infection and cell proliferation. PLoS Pathog 8:e1002479
Lu, Jie; Murakami, Masanao; Verma, Subhash C et al. (2011) Epstein-Barr Virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin. Virology 410:64-75
Cai, Qiliang; Guo, Yi; Xiao, Bingyi et al. (2011) Epstein-Barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis. PLoS Pathog 7:e1002418
Saha, Abhik; Robertson, Erle S (2011) Functional modulation of the metastatic suppressor Nm23-H1 by oncogenic viruses. FEBS Lett 585:3174-84
Verma, Subhash C; Lu, Jie; Cai, Qiliang et al. (2011) Single molecule analysis of replicated DNA reveals the usage of multiple KSHV genome regions for latent replication. PLoS Pathog 7:e1002365
Saha, Abhik; Robertson, Erle S (2011) Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes. Clin Cancer Res 17:3056-63

Showing the most recent 10 out of 60 publications